Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Myasthenia Gravis
×
Bortezomib
×
Clear all
Filters
3
NCT02102594
2019-12-03
TAVAB
Charite University, Berlin, Germany
Phase 2
Terminated
11 enrolled